Is this your firm? Get featured or correct your listing →
At a glance
Quadrille Capital appears in 3 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was Reco's $55M round (Oct 1, 2026).
Recent changes
- Oct 1, 2026Oct 1, 2026Invested in Reco ($55M) The SaaS News
- Sep 24, 2026Sep 24, 2026Invested in BigHat Biosciences (Series C, $75M) BioSpace
- Jul 1, 2026Jul 1, 2026Invested in TwelveLabs (Series B, $100M) PYMNTS
Portfolio
4 totalRecent Investment Activity
3Track record: led 0 and participated in 3 of 3 tracked venture rounds · 3 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 2026 | Reco | funding round | Participated | $55M | — | The SaaS News | |
| Sep 24, 2026 | BigHat Biosciences | Series C | Participated | $75M | — | DFJ GrowthLeadPremji InvestLeadCatalio Capital ManagementLG Technology Ventures8VCAndreessen HorowitzEli Lilly and CompanyMerck Global Health Innovation FundQuadrille CapitalGRIDS CapitalIntermountain VenturesSection 32Sigmas GroupAmgen VenturesAlexandria Venture InvestmentsDiscovery Ventures | BioSpace |
| Jul 1, 2026 | TwelveLabs | Series B | Participated | $100M | — | PYMNTS |
Sector / Stage Activity
Co-Investors
12Similar Firms
overlapping sector, stage or regionLatest Pulse
- Oct 1, 2026Reco Raises $55M, Pushing Total Funding To $140MAgentic security startup Reco raised $55 million in additional funding, including a strategic investment from AT&T Ventures, bringing its total capital raised to $140 million.→
- Sep 30, 2026Reco Raises $55M To Expand Agentic SecurityReco raised $55 million including a strategic investment from AT&T Ventures to expand its platform for governing what AI agents can do inside enterprise SaaS and cloud systems.→
- Sep 24, 2026BigHat Biosciences Raises $75M To Scale AI Antibody DesignBigHat Biosciences closed a $75 million Series C co-led by DFJ Growth and Premji Invest, taking total funding to $223 million as its AI-designed antibody-drug conjugate enters a Phase 1 trial for gastric cancer.→
- Aug 3, 2026TwelveLabs Raises $100M to Build Video SuperintelligenceTwelveLabs raised a $100M Series B co-led by NEA and NAVER Ventures to expand beyond video-understanding models into a full-stack agentic system combining perception, knowledge and reasoning for video.→
- Jul 1, 2026TwelveLabs Raises $100M Series B to Build 'Video Superintelligence,' Deepens AWS PartnershipTwelveLabs closed a $100 million Series B on July 1, co-led by NEA and Naver Ventures with Amazon participating directly, pushing total funding above $200 million. The company builds foundation models that understand video the way humans do, and is expanding from video-understanding models into a full-stack agentic system combining perception, knowledge and reasoning, while committing AWS Trainium as its preferred inference chip.→
Quadrille Capital FAQ
What companies has Quadrille Capital invested in?
Quadrille Capital's portfolio includes Reco, BigHat Biosciences, TwelveLabs, AMBOSS TECHNOLOGIES.
Who does Quadrille Capital co-invest with most?
In the rounds Value Add tracks, Quadrille Capital most often invests alongside 8VC (1 shared deal), Amazon (1 shared deal), Andreessen Horowitz (1 shared deal), AT&T Ventures (1 shared deal), Boldstart Ventures (1 shared deal).
Sources & methodologyshow
- BioSpaceresearch database1 fact
- The SaaS Newsresearch database1 fact
- PYMNTSValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.